Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (378)
- Scheduling (national classification system) (176)
- Safety monitoring and information (31)
- COVID-19 (11)
- Manufacturing (11)
- Advertising (9)
- Clinical trials (8)
- Medicinal cannabis hub (6)
- Compliance and enforcement (5)
- Fees and payments (5)
- Sunscreens (5)
- Shortages and supply disruptions (4)
- Legislation (3)
- Breast implant hub (1)
- Import and export (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
773 result(s) found, displaying 226 to 250
-
Meeting statementsMeeting statement from meeting 9 of the Medical Devices Consumer Working Group (MDCWG).
-
Meeting statementsMeeting statement from the Advisory Committee on Medical Devices (ACMD), December 2022.
-
Scheduling decisions (final)Public notice of final decisions to amend (or not amend) the Poisons Standard - ACMS, ACCS and joint ACMS-ACCS, June 2022
-
Meeting statementsCommunique from the 2nd meeting of the Women's Health Products Working Group (WHPWG), 20 October 2022
-
Scheduling submissionsPublic submissions on interim decisions for scheduling matters referred to ACMS, ACCS and Joint meetings held in November 2021
-
Meeting statementsMeeting statement from meeting 8 of the Medical Devices Consumer Working Group (MDCWG).
-
Scheduling submissionsPublic submissions on interim decisions for scheduling matters referred to ACMS, ACCS and Joint meetings held in June 2021
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsMeeting statement from the Advisory Committee on Medical Devices (ACMD), October 2022.
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Scheduling submissionsPublic submissions made in response to the public consultation on proposed amendments to the Poisons Standard - November 2021 ACMS/ACCS meetings
-
Scheduling submissionsPublic submissions made in response to the public consultation on proposed amendments to the Poisons Standard - June 2022 ACMS/ACCS meetings
-
Corporate reportsDocuments released under the FOI Act in the 2021/22 financial year
-
Corporate reportsThis Cost Recovery Implementation Statement provides information on how the TGA, within the Department of Health, implements and cost recovers its regulatory activities
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Corporate reportsThe 2020-21 TGA Regulator Performance Report has now been published.
-
Corporate reportsThe TGA Pharmacovigilance Inspection Program (PVIP) metrics report for 2021 is now available.
-
Scheduling decisions (final)Public notice of final decision to amend (or not to amend) the Poisons Standard, ACMS #37, ACCS #33, Joint ACMS-ACCS #30
-
Scheduling decisions (final)Public notice of final decision to amend (or not amend) the Poisons Standard, Joint ACMS-ACCS #29 in November 2021.
-
Corporate reportsTGA's Access Statement on Good Manufacturing Practice (GMP) Inspections Reliance and Recognition.
-
Meeting statementsAdvisory Committee on Vaccines, meeting 34, held 6 July 2022